These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 20573274)

  • 21. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
    Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
    Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
    Leang R; Ros S; Duong S; Navaratnam V; Lim P; Ariey F; Kiechel JR; Ménard D; Taylor WR
    Malar J; 2013 Sep; 12():343. PubMed ID: 24060207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border.
    Huang F; Tang L; Yang H; Zhou S; Sun X; Liu H
    Malar J; 2012 Aug; 11():278. PubMed ID: 22898135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
    Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.
    Rutvisuttinunt W; Chaorattanakawee S; Tyner SD; Teja-Isavadharm P; Se Y; Yingyuen K; Chaichana P; Bethell D; Walsh DS; Lon C; Fukuda M; Socheat D; Noedl H; Schaecher K; Saunders DL
    Malar J; 2012 Sep; 11():325. PubMed ID: 22974086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.
    Gosi P; Lanteri CA; Tyner SD; Se Y; Lon C; Spring M; Char M; Sea D; Sriwichai S; Surasri S; Wongarunkochakorn S; Pidtana K; Walsh DS; Fukuda MM; Manning J; Saunders DL; Bethell D
    Malar J; 2013 Nov; 12():403. PubMed ID: 24206588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyronaridine-artesunate Efficacy and Safety in Uncomplicated Plasmodium falciparum Malaria in Areas of Artemisinin-resistant Falciparum in Viet Nam (2017-2018).
    Quang Bui P; Hong Huynh Q; Thanh Tran D; Thanh Le D; Quang Nguyen T; Van Truong H; Khim N; Witkowski B; Cong Tran D; Bustos MD; Ringwald P; Thi Ta T
    Clin Infect Dis; 2020 May; 70(10):2187-2195. PubMed ID: 31251812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort.
    Laochan N; Zaloumis SG; Imwong M; Lek-Uthai U; Brockman A; Sriprawat K; Wiladphaingern J; White NJ; Nosten F; McGready R
    Malar J; 2015 May; 14():221. PubMed ID: 26017553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
    Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
    Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction.
    Lo E; Nguyen J; Oo W; Hemming-Schroeder E; Zhou G; Yang Z; Cui L; Yan G
    BMC Infect Dis; 2016 Apr; 16():154. PubMed ID: 27084511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.
    Liu H; Yang HL; Tang LH; Li XL; Huang F; Wang JZ; Li CF; Wang HY; Nie RH; Guo XR; Lin YX; Li M; Wang J; Xu JW
    Malar J; 2015 Feb; 14():47. PubMed ID: 25652213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Dihydroartemisinin-Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam.
    Tran THT; Hien BTT; Dung NTL; Huong NT; Binh TT; Van Long N; Ton ND
    Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929629
    [No Abstract]   [Full Text] [Related]  

  • 39. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.